Publication | Closed Access

A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro

Cell TherapyCancer ImmunosurveillanceMedicineOptimal Dc MaturationImmunologyTumor ImmunityT Cell ImmunityClinical Grade PolyCell BiologyCellular Immune ResponseImmunotherapyOncologyCell TransplantationHealthy DonorsCancer Research